menu
    • menu

    Company profile for Unravel Biosciences

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Unravel Biosciences is a therapeutics company spun out from the Wyss Institute at Harvard University that seamlessly bridges target discovery with clinical efficacy to advance drugs for complex neurological diseases where traditional target-driven drug programs have often failed. Unravel leverages its proprietary BioNAV™ platform combining AI drug discovery, patient stratification, preclinical screening, and rapid clinical t...
    Unravel Biosciences is a therapeutics company spun out from the Wyss Institute at Harvard University that seamlessly bridges target discovery with clinical efficacy to advance drugs for complex neurological diseases where traditional target-driven drug programs have often failed. Unravel leverages its proprietary BioNAV™ platform combining AI drug discovery, patient stratification, preclinical screening, and rapid clinical trials to discover effective treatments for complex diseases impacting the whole body.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Unravel BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Morrissey Blvd, UMass Boston Venture Development Center, Boston, MA 02125
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.unravel.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/unravel-biosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Unravel Biosciences, SCN2A Foundation Partner On Drug Discovery
    Unravel Biosciences, SCN2A Foundation Partner On Drug Discovery

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128305964/en/Unravel-Biosciences-and-The-SCN2A-Foundation-Announce-Drug-Discovery-Collaboration

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Evogene, Unravel Biosciences Partner To Develop Novel Therapy
    Evogene, Unravel Biosciences Partner To Develop Novel Therapy

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evogene-and-unravel-biosciences-announce-collaboration-to-develop-a-first-in-class-therapy-to-reverse-neurological-damage-in-demyelinating-disorders-302655069.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Unravel Biosciences To Start RVL-001 Trials For Rett Syndrome
    Unravel Biosciences To Start RVL-001 Trials For Rett Syndrome

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202077465/en/Unravel-Biosciences-Announces-Approval-by-Colombian-Health-Regulatory-Authority-to-Initiate-RVL-001-Clinical-Studies-for-Rett-Syndrome-and-Pitt-Hopkins-Syndrome

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    Unravel Biosciences And Jackson Lab Collaborate To Accelerate Drug Discovery
    Unravel Biosciences And Jackson Lab Collaborate To Accelerate Drug Discovery

    17 Sep 2024

    // #N/A

    https://www.prnewswire.com/news-releases/unravel-biosciences-and-the-jackson-laboratory-announce-collaboration-to-accelerate-the-discovery-of-promising-drugs-for-diseases-with-high-unmet-need-302250206.html

    #N/A
    17 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search